Skip to main content

Posts

Critical Analysis: Intra-Cellular Therapies, Inc. v. Controller of Patents

  Critical Analysis: Intra-Cellular Therapies, Inc. v. Controller of Patents (2026:DHC:5394) C.A.(COMM.IPD-PAT) 24/2023 | Delhi High Court | Decided: 06.07.2026 I. Doctrinal Analysis: Novelty and the "Coverage vs. Disclosure" Question A. The genus-species anticipation problem The core novelty dispute was a classic Markush-genus-versus-species-selection issue. The appellant argued that arriving at the claimed species from the generic Formula I of D1/D7 required " multiple selections " among independent variables (R1–R6), and that the Controller impermissibly relied on more than one prior art document to construct a single "closest prior art" novelty attack — a submission with real doctrinal pedigree, since novelty (unlike obviousness) is ordinarily tested against a single prior document read as a whole. The Court's response — invoking AstraZeneca AB and Boehringer Ingelheim v. Vee Excel — collapses the " covered vs. disclosed " dist...
Post a Comment
Read more

India Releases Comprehensive Concept Note on Proposed Amendments to the Designs Act, 2000: Paradigm Shift Toward Digital Innovation and International Integration

  Summary The Controller General of Patents, Designs and Trademarks has published a comprehensive Concept Note outlining transformative amendments to the Designs Act, 2000. The proposed reforms introduce groundbreaking protection for non-tangible design forms including GUIs, virtual reality interfaces, and animations; clarify the design-copyright interface to prevent perpetual monopolies; establish a full 12-month grace period for all types of disclosures; enable deferred publication aligned with the Hague Agreement; introduce statutory damages up to ₹50 lakhs for willful infringement; restructure protection terms to a 5+5+5 system; permit multiple designs in single applications; enable divisional applications; and incorporate comprehensive provisions for international registration under the Hague Agreement, positioning India as a global hub for design innovation. Overview: A New Era for Indian Design Protection The Controller General of Patents, Designs and Trademarks has released...
Post a Comment
Read more

China Unveils Major Amendments to Patent Examination Guidelines: New Standards for AI, Biotechnology, and Dual Filings Take Effect January 1, 2026

  Summary The China National Intellectual Property Administration (CNIPA) has announced comprehensive amendments to the Patent Examination Guidelines, effective January 1, 2026. The revised Guidelines introduce significant changes to inventor disclosure requirements, dual filing procedures, inventiveness assessment standards, re-examination protocols, and specialized examination criteria for artificial intelligence and bitstream-related inventions, marking a substantial modernization of China's patent examination framework. Overview of the Revised Guidelines On January 1, 2026, the China National Intellectual Property Administration (CNIPA) will implement substantially revised  Patent Examination Guidelines , introducing fundamental changes to patent examination procedures, substantive assessment criteria, and administrative practices. These amendments represent the most comprehensive update to China's patent examination framework in recent years, addressing emerging technolog...
Post a Comment
Read more